Stock Quotes & Company News | Reuters.com
Edition:
United States

People: INSYS Therapeutics Inc (INSY.OQ)

INSY.OQ on NASDAQ Stock Exchange Global Market

13.04USD
11:20am EDT
Change (% chg)

$0.10 (+0.77%)
Prev Close
$12.94
Open
$13.14
Day's High
$13.21
Day's Low
$12.81
Volume
45,786
Avg. Vol
215,037
52-wk High
$46.10
52-wk Low
$11.46

Baker, Darryl 

Mr. Darryl S. Baker is Chief Financial Officer of Insys Therapeutics, Inc. From 2001 to 2012, Mr. Baker served as Chief Financial Officer and Corporate Controller for iGo, a developer of power management solutions and accessories for mobile electronic devices. From 2000 to 2001, Mr. Baker served as the Corporate Controller for Integrated Information Systems, Inc., a provider of secure integrated information technology solutions. From 1997 to 1999, Mr. Baker served as the Corporate Controller for SkyMall, Inc., a specialty retailer. Prior to 1997, Mr. Baker was an audit manager for Ernst & Young. Mr. Baker earned his B.S. in Accountancy from the Marriott School of Management at Brigham Young University and is a Certified Public Accountant in the states of California and Arizona and is also a Chartered Global Management Accountant. We believe that Mr. Baker has extensive experience in accounting, SEC compliance for smaller public companies, merger and acquisition transactions, and small business financing and frequently serves as a panelist and lecturer for the Center for Professional Education on various topics including SEC compliance, share-based compensation, revenue recognition, fair value and lease accounting.

Basic Compensation

Total Annual Compensation, USD 383,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 827,087
Fiscal Year Total, USD 1,210,090

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --